Novo Integrated Sciences (NVOS) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart

Novo Integrated Sciences Revenue Highlights

Latest Revenue (Y)

$12.57M

Latest Revenue (Q)

$3.15M

Main Segment (Y)

Corporate Segment

Novo Integrated Sciences Revenue by Period

Novo Integrated Sciences Revenue by Year

Date	Revenue	Change
2023-08-31	$12.57M	7.11%
2022-08-31	$11.74M	26.14%
2021-08-31	$9.31M	18.38%
2020-08-31	$7.86M	-16.57%
2019-08-31	$9.42M	5.93%
2018-08-31	$8.89M	11.70%
2017-08-31	$7.96M	10.93%
2016-08-31	$7.18M	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	100.00%
2011-12-31	-	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	100.00%
2005-12-31	-	100.00%
2004-12-31	-	-

Novo Integrated Sciences generated $12.57M in revenue during NA 2023, up 7.11% compared to the previous quarter, and up 141.35% compared to the same period a year ago.

Novo Integrated Sciences Revenue by Quarter

Date	Revenue	Change
2024-05-31	$3.15M	-0.59%
2024-02-29	$3.17M	-18.52%
2023-11-30	$3.89M	17.80%
2023-08-31	$3.30M	0.31%
2023-05-31	$3.29M	28.81%
2023-02-28	$2.56M	-25.23%
2022-11-30	$3.42M	-141.98%
2022-08-31	$-8.15M	-158.80%
2022-05-31	$13.85M	382.77%
2022-02-28	$2.87M	-9.26%
2021-11-30	$3.16M	17.42%
2021-08-31	$2.69M	13.10%
2021-05-31	$2.38M	14.70%
2021-02-28	$2.08M	-3.69%
2020-11-30	$2.16M	16.84%
2020-08-31	$1.84M	77.69%
2020-05-31	$1.04M	-57.25%
2020-02-29	$2.43M	-4.70%
2019-11-30	$2.55M	5.30%
2019-08-31	$2.42M	-2.79%
2019-05-31	$2.49M	13.14%
2019-02-28	$2.20M	-4.81%
2018-11-30	$2.31M	6.45%
2018-08-31	$2.17M	-6.52%
2018-05-31	$2.32M	8.26%
2018-02-28	$2.15M	-4.78%
2017-11-30	$2.25M	1.51%
2017-08-31	$2.22M	6.24%
2017-05-31	$2.09M	100.00%
2017-02-28	-	-100.00%
2016-12-31	$1.82M	-0.94%
2016-09-30	$1.84M	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	100.00%
2007-09-30	-	100.00%
2007-06-30	-	-

Novo Integrated Sciences generated $3.15M in revenue during Q3 2024, up -0.59% compared to the previous quarter, and up 123.29% compared to the same period a year ago.

Novo Integrated Sciences Revenue Breakdown

Novo Integrated Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Aug 23	Aug 22	Aug 21
Corporate Segment	$9.70K	$3.18K	-
Healthcare Services	-	$8.40M	$8.86M
Product Sales	-	$3.34M	-
Product Manufacturing and Development	-	-	$447.56K

Novo Integrated Sciences's latest annual revenue breakdown by segment (product or service), as of Aug 23: Corporate Segment (100.00%).

Quarterly Revenue by Product

Product/Service	May 24	Nov 23	Aug 23	May 23	Aug 22	May 22	Feb 22	Nov 21
Product Manufacturing And Development	$968.52K	-	-	-	-	-	-	-
Corporate Segment	-	$78.25K	-	-	-	-	-	-
Product Manufacturing and Development	-	-	-	$1.27M	$995.65K	$982.30K	-	-
Healthcare Services	-	-	-	$2.02M	$2.14M	-	-	-
Product Sales	-	-	-	-	$-10.29M	$11.65M	-	-
HealthCare Services	-	-	-	-	-	$2.20M	$1.87M	$2.18M

Novo Integrated Sciences's latest quarterly revenue breakdown by segment (product or service), as of May 24: Product Manufacturing And Development (100.00%).

Novo Integrated Sciences Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
THC	Tenet Healthcare	$20.55B	$5.12B
UHS	Universal Health Services	$14.28B	$3.96B
CYH	Community Health Systems	$12.49B	$3.09B
DVA	DaVita	$12.14B	$3.26B
AGL	agilon health	$4.32B	$1.45B
AMN	AMN Healthcare Services	$3.79B	$687.51M
BKD	Brookdale Senior Living	$3.02B	$784.17M
ACHC	Acadia Healthcare Company	$2.93B	$815.63M
CANO	Cano Health	$2.74B	$788.07M
AVAH	Aveanna Healthcare	$1.90B	$509.02M
PIII	P3 Health Partners	$1.27B	$362.12M
LFST	LifeStance Health Group	$1.06B	$312.72M
PNTG	Pennant Group	$544.89M	$168.75M
TOI	Oncology Institute	$324.24M	$99.90M
NVOS	Novo Integrated Sciences	$12.57M	$3.15M
BACK	IMAC	$5.20M	-

NVOS Revenue FAQ

What is Novo Integrated Sciences’s yearly revenue?

Novo Integrated Sciences's yearly revenue for 2023 was $12.57M, representing an increase of 7.11% compared to 2022. The company's yearly revenue for 2022 was $11.74M, representing an increase of 26.14% compared to 2021. NVOS's yearly revenue for 2021 was $9.31M, representing an increase of 18.38% compared to 2020.

What is Novo Integrated Sciences’s quarterly revenue?

Novo Integrated Sciences's quarterly revenue for Q3 2024 was $3.15M, a -0.59% decrease from the previous quarter (Q2 2024), and a -4.28% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $3.17M, a -18.52% decrease from the previous quarter (Q1 2024), and a 24.02% increase year-over-year (Q2 2023). NVOS's quarterly revenue for Q1 2024 was $3.89M, a 17.80% increase from the previous quarter (Q4 2023), and a 13.80% increase year-over-year (Q1 2023).

What is Novo Integrated Sciences’s revenue growth rate?

Novo Integrated Sciences's revenue growth rate for the last 3 years (2021-2023) was 35.11%, and for the last 5 years (2019-2023) was 33.44%.

What are Novo Integrated Sciences’s revenue streams?

Novo Integrated Sciences's revenue streams in g 23 are Corporate Segment

What is Novo Integrated Sciences’s main source of revenue?

For the fiscal year ending Aug 23, the largest source of revenue of Novo Integrated Sciences was Corporate Segment. This segment made a revenue of $9.7K, representing 100.00% of the company's total revenue.